Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Non-Current Assets: 2020-2024

Historic Non-Current Assets for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $4.8 million.

  • Molecular Partners Ag's Non-Current Assets fell 26.18% to $3,988 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,988, marking a year-over-year decrease of 26.18%. This contributed to the annual value of $4.8 million for FY2024, which is 73473.98% up from last year.
  • Per Molecular Partners Ag's latest filing, its Non-Current Assets stood at $4.8 million for FY2024, which was up 73,473.98% from $6,562 recorded in FY2023.
  • Molecular Partners Ag's 5-year Non-Current Assets high stood at $10.8 million for FY2020, and its period low was $6,562 during FY2023.
  • Its 3-year average for Non-Current Assets is $1.6 million, with a median of $7,791 in 2022.
  • Its Non-Current Assets has fluctuated over the past 5 years, first crashed by 99.91% in 2021, then spiked by 73,473.98% in 2024.
  • Molecular Partners Ag's Non-Current Assets (Yearly) stood at $10.8 million in 2020, then plummeted by 99.91% to $9,193 in 2021, then dropped by 15.25% to $7,791 in 2022, then decreased by 15.78% to $6,562 in 2023, then skyrocketed by 73,473.98% to $4.8 million in 2024.